Business Wire

CT-CIDRA-MINERALS

19.12.2022 10:01:39 CET | Business Wire | Press release

Share
CiDRA Minerals Processing and OZ Minerals enter into Memorandum of Understanding

CiDRA Minerals Processing Inc. (“CiDRA”) and OZ Minerals Ltd (“OZ Minerals”) are pleased to announce that they have entered into a Memorandum of Understanding that provides a basis of common understanding to commission a Front End Engineering Design (FEED) study for customization and tie-in of CiDRA’s proprietary mineral separation technology for operation in a grind circuit rougher application at OZ Minerals’ Carrapateena Mine Site. At the same time, CiDRA and OZ Minerals have agreed to deploy a demonstration plant based on CiDRA’s technology at the site. CiDRA and OZ Minerals share a desire to increase the technology readiness level (TRL) for a commercial scale implementation of CiDRA’s technology as a grind circuit rougher which will process a coarse fraction of the primary grind hydrocyclone underflow at Carrapateena. The goals of the Partnership are to increase plant throughput, recovery, and net metal production at a reduced specific energy consumption in keeping with their efforts to help meet the world’s raw material needs in a responsible, equitable, and sustainable way.

“We are excited to take this next step in our relationship with OZ Minerals. Since early 2022, we have been working closely with the Carrapateena Mine Site to evaluate the potential benefits of CiDRA’s technology. This new technology enables a robust process that can recover mineral particles across a size range from ultra-fine to very coarse with high selectivity and minimal hydraulic entrainment. Applying CiDRA’s novel technology as a grind circuit rougher unlocks the concentrator’s throughput capacity while maintaining world class mineral recovery. The MOU will allow us to collectively focus our efforts to leverage this incredible innovation to enhance the net metal production of the Carrapateena Mine Site and create a tremendous value for each of our companies,” stated Paul Rothman, President of CiDRA.

Joe Seppelt, Manager-Processing at OZ Minerals’ Carrapateena Mine Site stated: “The CiDRA technology can enable us to increase our plant throughput without sacrificing the industry leading recoveries that we have been able to achieve at Carrapateena. This capital efficient approach has the potential to operate with less water and energy and with a smaller footprint. We look forward to working with CiDRA to realize the benefits of their innovation.”

About CiDRA Minerals Processing

CiDRA Minerals Processing develops advanced technologies and solutions that create new paradigms in the minerals processing industry with a focus on increasing enterprise value through optimization, increased recoveries and enhancing the sustainability of limited and valuable resources. CiDRA Minerals Processing provides measurement and control solutions to over 460 mine sites in 46 countries.

About OZ Minerals

At OZ Minerals we strive to be modern. We’re guided by our purpose, “Going beyond what’s possible to make lives better”. We believe that only when we create value for all our stakeholders will we be successful and sustainable. Our framework of systems and behaviours we call The OZWay, guides us while giving us the freedom and pathways to achieve our aspirations and purpose. We are passionate about creating an inclusive culture where people challenge, innovate, learn and grow together. By ethically and responsibly exploring for and mining copper we contribute to a low carbon future and economic wellbeing which, in turn, helps us achieve our purpose and contribute to a better future.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221218005016/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press release

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press release

£175m for first Haleon manufacturing site in Madhya Pradesh, central IndiaFast-growing India key to Haleon reaching one billion more consumers by 2030India’s consumer health market to reach over £23bn by 20301Accelerated rural distribution to access 3 million outletsAffordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/e

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press release

Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at World ADA Diabetes & Obesity Conference Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the int

Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press release

Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press release

Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye